Literature DB >> 22955033

Peptide sequences mediating tropism to intact blood-brain barrier: an in vivo biodistribution study using phage display.

Mathew W Smith1, Ghaith Al-Jayyoussi, Mark Gumbleton.   

Abstract

Peptide motifs that demonstrate tropism for the blood brain barrier (BBB) are of real translational value in developing innovative delivery strategies for biological brain targeted therapies. In vivo peptide-phage display affords peptide selection against the full complement of biological markers within the correct cellular macro- and micro-environments. Here a stringent in vivo biopanning protocol was employed in the rat aimed at identifying cyclic 7-mer peptide motifs that mediate tropism to brain microvasculature. Five rounds of biopanning identified 349 unique peptide motifs in the brain tissue gray matter compartment (microvasculature and parenchyma). While in general no consensus was evident linking peptide physico-chemical properties and brain tropism, peptides bearing c-SxTSSTx-c or c-xxxSSTx-c motifs were found to be present in high abundance. Based on amino acid frequency distribution of the 349 unique peptides sequences a theoretical 'idealized' peptide pattern, c-PP(S/P)SSST-c, could be derived. For the most abundant experimental peptide sequence found in brain tissue, c-SYTSSTM-c, an in vivo pharmacokinetic and whole body tissue biodistribution study was performed. Based upon tissue exposure data (i.e. tissue AUC((0-infinity))) the sequence c-SYTSSTM-c efficiently retargeted phage virions to the brain providing an approximate 5-fold greater (P<0.05) accumulation in brain over control phage; in all other organs no significant (P>0.05) difference in tissue tropism between c-SYTSSTM-c and control phages were evident. This peptide and more generally the peptide motifs, -SxTSSTx- or -xxxSSTx-, warrant further investigation as agents mediating sequence-dependent tropism to brain microvasculature potentially able to deliver biologic cargo to the CNS.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22955033     DOI: 10.1016/j.peptides.2012.06.019

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  A Peptide Targeting Inflammatory CNS Lesions in the EAE Rat Model of Multiple Sclerosis.

Authors:  Claudine Boiziau; Macha Nikolski; Elodie Mordelet; Justine Aussudre; Karina Vargas-Sanchez; Klaus G Petry
Journal:  Inflammation       Date:  2018-06       Impact factor: 4.092

2.  An innovative strategy to identify new targets for delivering antibodies to the brain has led to the exploration of the integrin family.

Authors:  Céline Cegarra; Béatrice Cameron; Catarina Chaves; Tarik Dabdoubi; Tuan-Minh Do; Bruno Genêt; Valérie Roudières; Yi Shi; Patricia Tchepikoff; Dominique Lesuisse
Journal:  PLoS One       Date:  2022-09-15       Impact factor: 3.752

3.  Peptides as drug delivery vehicles across biological barriers.

Authors:  Debadyuti Ghosh; Xiujuan Peng; Jasmim Leal; Rashmi Mohanty
Journal:  J Pharm Investig       Date:  2017-12-12

4.  DNA Subtraction of In Vivo Selected Phage Repertoires for Efficient Peptide Pathology Biomarker Identification in Neuroinflammation Multiple Sclerosis Model.

Authors:  Karina Vargas-Sanchez; Antonios Vekris; Klaus G Petry
Journal:  Biomark Insights       Date:  2016-02-16

5.  Cargo Delivery into the Brain by in vivo identified Transport Peptides.

Authors:  Eduard Urich; Roland Schmucki; Nadine Ruderisch; Eric Kitas; Ulrich Certa; Helmut Jacobsen; Christophe Schweitzer; Alessandra Bergadano; Martin Ebeling; Hansruedi Loetscher; Per-Ola Freskgård
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

6.  Phage Peptide Libraries As a Source of Targeted Ligands.

Authors:  A A Nemudraya; V A Richter; E V Kuligina
Journal:  Acta Naturae       Date:  2016 Jan-Mar       Impact factor: 1.845

7.  Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging.

Authors:  Mallika Asar; Jessica Newton-Northup; Susan Deutscher; Mette Soendergaard
Journal:  Diagnostics (Basel)       Date:  2019-11-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.